MétaCan
Menu
Back to cohort
Record W3129849844 · doi:10.1158/1055-9965.epi-20-1613

Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer

2021· article· en· W3129849844 on OpenAlexfundno aff
Melissa A. Merritt, Howard D. Strickler, Alan D. Hutson, Mark H. Einstein, Thomas E. Rohan, Xiaonan Xue, Mark E. Sherman, Louise A. Brinton, Herbert Yu, David S. Miller, Nilsa C. Ramirez, Heather A. Lankes, Michael J. Birrer, Gloria S. Huang, Marc J. Gunter

Bibliographic record

VenueCancer Epidemiology Biomarkers & Prevention · 2021
Typearticle
Languageen
FieldMedicine
TopicEndometrial and Cervical Cancer Treatments
Canadian institutionsnot available
FundersNational Center for Advancing Translational SciencesCancer Center, University of ColoradoWalter Reed National Military Medical CenterUniversity of North Carolina at Chapel HillUniversity of Illinois at Urbana-ChampaignNational Institutes of HealthNorthwestern UniversityYork UniversityNRG OncologyWayne State UniversityAmerican Congress of Obstetricians and GynecologistsBrody School of MedicinePennsylvania State UniversityNorthShore University HealthSystemUniversity of OklahomaUniversity of CincinnatiStony Brook UniversityUniversity of PittsburghCancer Institute, University of PittsburghUniversity of MinnesotaCase Western Reserve UniversityCleveland ClinicCleveland Clinic FoundationUniversity of Oklahoma Health Sciences CenterAlbert Einstein Cancer CenterNational Cancer InstituteWake Forest UniversityOhio State UniversityGeorgia Clinical and Translational Science AllianceUniversity of PennsylvaniaYale UniversityWorld Health Organization
KeywordsEndometrial cancerInternal medicineMedicineInsulinEndocrinologySex hormone-binding globulinInsulin-like growth factorEstrogenCancerEstroneHormoneOncologyReceptorGrowth factorAndrogen

Abstract

fetched live from OpenAlex

BACKGROUND: The influence of sex hormone and insulin/insulin-like growth factor (IGF) axis signaling on endometrial cancer recurrence is unknown. We evaluated these pathways in a prospective cohort of Gynecologic Oncology Group (GOG)0210 trial endometrial adenocarcinoma patients. METHODS: , insulin (IR) and IGF-I receptors (IGF1R), phosphorylated IR/IGF1R (pIGF1R/pIR), and estrogen (ER) and progesterone receptors (PR) using qPCR and IHC. Serum concentrations of insulin, IGF-I, IGFBP-3, estradiol, estrone, and sex hormone binding globulin were measured. HRs and 95% confidence intervals (CI) for progression-free survival were calculated from Cox models adjusting for age, stage, and grade. RESULTS: Recurrence occurred in 280 (34%) cases during a median of 4.6 years of follow-up. ER positivity (HR, 0.67; 95% CI, 0.47-0.95), IR positivity (HR, 0.53; 95% CI, 0.29-0.98), and circulating IGF-I (highest vs. lowest quartile: HR, 0.66; 95% CI, 0.47-0.92) were inversely associated with recurrence risk. Circulating estradiol (highest vs. lowest tertile: HR, 1.55; 95% CI, 1.02-2.36) and pIGF1R/pIR positivity (HR, 1.40; 95% CI, 1.02-1.92) were associated with increased recurrence risk. CONCLUSIONS: Circulating estradiol and tumor tissue phosphorylated (activated) IGR1R/IR were independently associated with higher risk of recurrence in patients with endometrial cancer. IMPACT: This study may inform future clinical trials of endocrine-targeted adjuvant therapies in patients with endometrial cancer that could include baseline assessment of serum and tissue biomarkers of estradiol and insulin signaling pathways.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.001
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.067
GPT teacher head0.363
Teacher spread0.296 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations16
Published2021
Admission routes1
Has abstractyes

Explore more

Same venueCancer Epidemiology Biomarkers & PreventionSame topicEndometrial and Cervical Cancer TreatmentsFrench-language works237,207